Skip to main content
Signal8

Omega Fund Management, LLC

Omega Fund Management, LLC is an Investment Adviser institutional filer with the SEC under CIK 1637359, reporting 10 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Omega Fund Management, LLC's most recent 13F filing, ranked by reported market value.

  1. Bicara Therapeutics Inc. (BCAX)
  2. Nuvation Bio Inc. (NUVB)
  3. Kestra Med Technologies Ltd (KMTS)
  4. BridgeBio Oncology Therapeutics Inc. (BBOT)
  5. Beta Bionics Inc. (BBNX)
  6. Alumis Inc. (ALMS)
  7. Sana Biotechnology, Inc. (SANA)
  8. ImageneBio, Inc. (IMA)
  9. enGene Holdings Inc. (ENGN)
  10. Odyssey Therapeutics Inc. (ODTX)
/